Blood Cancer Journal (Jul 2022)
G-CSF plus azacitidine versus azacitidine alone for patients with high-risk myelodysplastic syndrome: academic, open label, randomized trial
Abstract
Trial registration GA trial is registered under EudraCT#: 2013-001639-38.
